Medical News
The Association between PT-INR and Long-term Mortality in Pa...
BMC Cardiovasc Disord.
Our study demonstrates high levels of PT-INR were associated with an increased risk of all-cause mortality.
01 Jul 2022
Empagliflozin for Heart Failure with Preserved Left Ventricu...
Circulation.
In patients with heart failure and a preserved ejection fraction enrolled in EMPEROR-Preserved (Empagliflozin...
30 Jun 2022
Post-operative Atrial Fibrillation and Risk of Heart Failure...
Eur Heart J.
Post-operative atrial fibrillation is associated with incident HF hospitalization among patients without prior...
29 Jun 2022
Effect of Vitamin D Supplementation on Cardiac-metabolic Ris...
Diabetol. metab. syndr.
The study suggests that VDS could improve insulin concentration and dyslipidemia in the elderly population.
28 Jun 2022
eCMEs
Key Trials
Treatment with Sacubitril/valsartan Associated with Improved Hemodynamic Status in Patients with HFrEF
According to the study, HFrEF patients treated with sacubitril/valsartan had improved hemodynamic status, as assessed by the changes in the...
Global Longitudinal Strain: A Robust and Independent Prognostic Indicator in Patients with HFimpEF
Global longitudinal strain is a strong and independent predictor for future HF events and deteriorating cardiac function in patients with HFimpEF....
ARNI Superior to ACEI/ARB in reducing CV Outcomes in Patients with Acute Myocardial Infarction
The study demonstrated ARNI to be superior to ACE inhibitor or ARB for reducing long-term adverse cardiovascular outcomes in patients with acute MI...
HFrEF Patients with Comorbidities, less likely to achieve NT-proBNP target: A Secondary Analysis of the GUIDE-IT
According to the secondary analysis of the GUIDE IT trial, patients with HFrEF and comorbidities such as AF, a lower BMI, or worse renal function...
Slide Library
Medical Management Strategy of CTEPH: Role of Riociguat
Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH
Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...
Chronic Thromboembolic Pulmonary Hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...
Diabetic Dyslipidemia
Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...
Our Publications
CARLOC-I (Carvedilol +Ivabradine) Monograph
Carvedilol/ivabradine have a proven chemical-pharmaceutical quality and are considered an approvable fixed-dose combination. Both carvedilol and...
Rivazest (Rivaroxaban) Monograph
Rivaroxaban is a potent, selective, orally active direct inhibitor of the activated serine protease Factor X (FXa), which plays a central role in...
Telyse (Tenecteplase) Monograph
In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....
Mexiletine FAQ Booklet
Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...
Patient Education
Understanding Angioplasty
Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.
Understanding Obesity
This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss.
Hypertension
Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure.
.jpg)
Poll
What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
20-40%
40-50%
50-70%
70-80%
Almost all
Total votes: 28